Medication info

Baclovir Tablet 200 mg (Acyclovir)

Prescription medicationExpired
Ingredient · strength
Acyclovir›Strength being verified
Manufacturer / importer
Handok Co., Ltd.
Appearance
It is a light blue round tablet.
Packaging
30 tablets/bottle
Approval status
Expired

MFDS item code 199400778 · Notified 1994.06.01

This product's status changed to Expired on 2023.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of herpes simplex; treatment of herpes zoster and pediatric chickenpox
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times a day at 4-hour intervals for 5 days. In cases of severe initial infection, treatment may be extended. 2) In patients with severe immunosuppression (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer as soon as possible after infection. In recurrent cases, it is preferable to start treatment when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug per dose 4 times a day at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered 2 times a day at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times a day after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for reassessment. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Administer 200 mg of this drug per dose 4 times a day at approximately 6-hour intervals. 2) In patients with severe immunosuppression (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug per dose 5 times a day at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunosuppression or gastrointestinal malabsorption. 3) Administer as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse reactions affecting the central nervous system; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose 2 times a day at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times a day at approximately 8-hour intervals.
Children's dosage
Age 2 years and older: Same as adults. Under 2 years: Administer 1/2 of the adult dose. Reliable data are not yet available on the prevention of herpes simplex virus infections in patients with normal immune function. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times a day for 5 days. Treatment is more effective the sooner it is started after the chickenpox rash appears; administer within 24 hours after the rash appears whenever possible.

Ingredients

Manufacturer
Handok Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex; treatment of herpes zoster and pediatric chickenpox

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infections of the skin and mucosal tissues
  • shingles virus infections
  • pain during acute phase
  • chickenpox.
View approved original text

This medication is used for the treatment and prevention of herpes simplex virus infections, including primary and recurrent genital herpes. It is also effective in the treatment of shingles virus infections and particularly helps relieve pain during the acute phase. However, its effectiveness against postherpetic neuralgia is still unclear. Additionally, it is utilized for the treatment of chickenpox in children aged 2 years and older. Overall, this medication is useful in treating a variety of viral infections and improving symptoms.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times a day at 4-hour intervals for 5 days. In cases of severe initial infection, treatment may be extended. 2) In patients with severe immunosuppression (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer as soon as possible after infection. In recurrent cases, it is preferable to start treatment when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug per dose 4 times a day at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered 2 times a day at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times a day after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for reassessment. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Administer 200 mg of this drug per dose 4 times a day at approximately 6-hour intervals. 2) In patients with severe immunosuppression (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug per dose 5 times a day at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunosuppression or gastrointestinal malabsorption. 3) Administer as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse reactions affecting the central nervous system; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose 2 times a day at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times a day at approximately 8-hour intervals.

Children's dosage

Age 2 years and older: Same as adults. Under 2 years: Administer 1/2 of the adult dose. Reliable data are not yet available on the prevention of herpes simplex virus infections in patients with normal immune function. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times a day for 5 days. Treatment is more effective the sooner it is started after the chickenpox rash appears; administer within 24 hours after the rash appears whenever possible.

Precautions

This medication should not be used in patients who are allergic to this medication or any of its components. Caution is required when using this medication in patients with poor kidney function, as central nervous system side effects may more easily manifest. Patients with poor liver function should be administered this drug carefully due to the risk of further deterioration of liver function. Special care should be taken when using this medication in infants and young children, and it should be used only when absolutely necessary. Elderly patients may have decreased kidney function, which could increase the risk of side effects from this medication, thus dosage and dosing intervals should be adjusted while ensuring adequate fluid intake. Rarely, severe allergic reactions such as anaphylactic shock may occur when using this drug, so symptoms should be monitored closely. If hypersensitivity reactions such as photosensitivity, skin rashes, fever, or hives occur, use should be discontinued immediately and appropriate treatment should be sought. Symptomatic manifestations such as hair loss, severe rashes, mucosal damage, etc., may occur, so if these symptoms appear, immediate consultation with healthcare professionals is necessary. Symptoms of mental confusion, hallucinations, seizures, drowsiness, anxiety, and various neurological abnormalities may occur, especially in elderly patients or those with reduced kidney function, necessitating caution. Kidney-related abnormalities such as worsening kidney function, hematuria, or proteinuria may occur, and regular testing is required. Various side effects, including blood abnormalities, liver function abnormalities, gastrointestinal issues, musculoskeletal pain, and circulatory issues, may occur, so any unusual symptoms should be reported immediately. If symptoms do not improve or worsen, alternative treatment methods should be considered, and early administration is effective. Patients with weakened immune systems may consider intravenous treatment with this medication. During the treatment period, adequate hydration should be maintained to reduce the risk of dehydration and kidney toxicity. Caution should be taken when performing hazardous activities such as driving or operating machinery due to the possibility of impaired consciousness. This medication may interact with other drugs, especially when used concurrently with medications affecting kidney function or specific drugs, so caution is needed. Pregnant women or women of childbearing potential should only use this medication after carefully weighing the risks and benefits, and its use should be avoided during breastfeeding. In cases of overdose, serious side effects involving the nervous system and kidneys may occur, so immediate medical assistance should be sought. High-dose administration of this medication could potentially affect genetic integrity or reproductive function; however, such effects have not been reported at standard dosages.

Side effects

  • anaphylactic shock
  • anaphylaxis-like reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 117 more
  • urticaria-like erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impaired concentration
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucination
  • psychosis
  • seizures
  • drowsiness
  • tremor
  • agitation
  • forgetfulness
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • ataxia
  • gait disturbances
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • soft stools
  • upper abdominal pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • systemic malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • sweating
  • hyponatremia
  • hypoproteinemia
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • anxiety
  • coma
  • seizures
  • drowsiness
  • confusion
  • hallucination
  • agitation
  • seizures
  • status epilepticus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture and should be kept in a cool, dry place at temperatures below 25 degrees Celsius. Proper storage will help maintain the efficacy of the medication for an extended period.

Appearance and packaging

Appearance

It is a light blue round tablet.

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.